Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

References for PMC Articles for PubMed (Select 19347621)

1.

Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90.

He H, Zatorska D, Kim J, Aguirre J, Llauger L, She Y, Wu N, Immormino RM, Gewirth DT, Chiosis G.

J Med Chem. 2006 Jan 12;49(1):381-90.

PMID:
16392823
2.

Modulating molecular chaperone Hsp90 functions through reversible acetylation.

Aoyagi S, Archer TK.

Trends Cell Biol. 2005 Nov;15(11):565-7. Epub 2005 Sep 30.

PMID:
16199163
3.

Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90.

Llauger L, He H, Kim J, Aguirre J, Rosen N, Peters U, Davies P, Chiosis G.

J Med Chem. 2005 Apr 21;48(8):2892-905.

PMID:
15828828
4.

Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation.

Citri A, Gan J, Mosesson Y, Vereb G, Szollosi J, Yarden Y.

EMBO Rep. 2004 Dec;5(12):1165-70.

5.

Small molecule modulation of the human chromatid decatenation checkpoint.

Haggarty SJ, Koeller KM, Kau TR, Silver PA, Roberge M, Schreiber SL.

Chem Biol. 2003 Dec;10(12):1267-79.

PMID:
14700634
6.

Targeted therapy for cancer: the HER-2/neu and Herceptin story.

Ross JS, Gray GS.

Clin Leadersh Manag Rev. 2003 Nov-Dec;17(6):333-40. Review.

PMID:
14692077
7.
8.

Microtiter cell-based assay for detection of agents that alter cellular levels of Her2 and EGFR.

Huezo H, Vilenchik M, Rosen N, Chiosis G.

Chem Biol. 2003 Jul;10(7):629-34.

PMID:
12890536
9.

Targeting HER1/EGFR: a molecular approach to cancer therapy.

Arteaga C.

Semin Oncol. 2003 Jun;30(3 Suppl 7):3-14. Review.

PMID:
12840796
10.

Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation.

Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4389-94. Epub 2003 Apr 3.

12.

Untangling the ErbB signalling network.

Yarden Y, Sliwkowski MX.

Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37. Review.

PMID:
11252954
13.

Overexpression of ErbB2 in cancer and ErbB2-targeting strategies.

Yu D, Hung MC.

Oncogene. 2000 Dec 11;19(53):6115-21. Review.

14.

Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis.

Haggarty SJ, Mayer TU, Miyamoto DT, Fathi R, King RW, Mitchison TJ, Schreiber SL.

Chem Biol. 2000 Apr;7(4):275-86. Erratum in: Chem Biol 2001 Dec;8(12):1265.

15.

Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors.

Klapper LN, Kirschbaum MH, Sela M, Yarden Y.

Adv Cancer Res. 2000;77:25-79. Review.

PMID:
10549355
16.

Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen.

Mayer TU, Kapoor TM, Haggarty SJ, King RW, Schreiber SL, Mitchison TJ.

Science. 1999 Oct 29;286(5441):971-4.

17.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk